Total Funding
25
42
Total FundingPost-IPO Equity raised
Growth Score
0 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
124386
G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology.
Acquired by 
Pharmacosmos Therapeutics
- Rajesh Malik: Chief Medical Officer
- Terry Murdock: Chief Operating Officer
Pharmacosmos Therapeutics
About the Company
G1 Therapeutics, Inc. is a commercial-stage oncology firm focused on the research and marketing of next-generation anticancer treatments.
